- Home
- HIMS
as 12-20-2024 4:00pm EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 6.6B | IPO Year: | N/A |
| Target Price: | $23.71 | AVG Volume (30 days): | 16.7M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.09 - $35.02 | Next Earning Date: | 11-04-2024 |
| Revenue: | $1,241,994,000 | Revenue Growth: | 56.70% |
| Revenue Growth (this year): | 71.33% | Revenue Growth (next year): | 37.95% |
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Dudum Andrew | HIMS | Chief Executive Officer | Dec 13 '24 | Sell | $30.01 | 409,814 | $12,488,567.87 | 522,864 | |
| Becklund Irene | HIMS | PAO | Dec 13 '24 | Sell | $30.89 | 10,484 | $336,348.16 | 7,319 | |
| Chi Michael | HIMS | Chief Commercial Officer | Dec 13 '24 | Sell | $32.20 | 25,550 | $822,710.00 | 193,601 | |
| Baird Melissa | HIMS | Chief Operating Officer | Dec 10 '24 | Sell | $31.21 | 85,561 | $2,653,128.90 | 639,199 | |
| Chi Michael | HIMS | Chief Commercial Officer | Dec 10 '24 | Sell | $32.25 | 7,259 | $234,102.75 | 193,601 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Dec 2 '24 | Sell | $33.38 | 33,513 | $1,118,653.89 | 522,864 | |
| Chi Michael | HIMS | Chief Commercial Officer | Dec 2 '24 | Sell | $33.56 | 2,054 | $68,932.24 | 193,601 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Nov 26 '24 | Sell | $29.90 | 2,343 | $70,055.70 | 165,254 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Nov 25 '24 | Sell | $27.45 | 101,993 | $3,021,496.10 | 207,574 | |
| Chi Michael | HIMS | Chief Commercial Officer | Nov 25 '24 | Sell | $26.49 | 17,303 | $458,356.47 | 193,601 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
Investor's Business Daily
3 days ago
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List
Yahoo Finance Video
3 days ago
Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls
Yahoo Finance
3 days ago
FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next
Argus Research
4 days ago
HIMS: Raising target price to $33.00
Yahoo Finance Video
5 days ago
Tesla, crypto miners, Hims & Hers Health: Trending Tickers
Business Wire
10 days ago
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
Argus Research
11 days ago
HIMS: Lowering target price to $32.00
Investor's Business Daily
17 days ago
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market
Compare HIMS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.